This edition of AI/ML for Early Drug Discovery Part 2 has already taken place.
Search future editions βHealthcare & MedTech
Exhibitor list
We do not have this show's exhibitor list
This show was held in April 2026. We hold no exhibitor list for AI/ML for Early Drug Discovery Part 2 2026. If the organiser does not make it public, we may never get it. Send us a request and we will try to find the exhibitors by searching.
Ask us to search for itA targeted session under the Drug Discovery Chemistry conference focusing on the application of artificial intelligence and machine learning in early-stage drug design, target identification, and molecular optimization.
Exhibitor mix: Sponsors and exhibitors categorized by product type, including AI platforms, CROs, and biotech services.
Exhibitor list
We do not have this show's exhibitor list
This show was held in April 2026. We hold no exhibitor list for AI/ML for Early Drug Discovery Part 2 2026. If the organiser does not make it public, we may never get it. Send us a request and we will try to find the exhibitors by searching.
Ask us to search for itOrganizer
Cambridge Healthtech Institute (CHI)
Subsidiary Β· Needham, United States Β· Founded 1992
Organizes life sciences conferences, training seminars, and reports focusing on drug discovery, development, and diagnostics.
Exhibitor list
You can see it by registering on the event website.
Why people attend
To find AI partners, automation tools, and data infrastructure solutions for speeding up drug discovery pipelines and improving molecular design success rates.
Who attends
Exhibitor categories
More Healthcare & MedTech events
More Healthcare & MedTech events
Frequently asked questions